2273 articles in this topic
Scientists develop comprehensive approaches to eliminate senescent cells in kidneys, potentially reversing age-related kidney decline.
New research shows senolytic drugs can eliminate therapy-resistant cells that fuel cancer recurrence, improving treatment outcomes.
New research reveals how drugs that eliminate senescent cells could complement existing Alzheimer's treatments by reducing brain inflammation.
New research maps the causal chain linking cellular aging to brain inflammation and cognitive decline, revealing intervention windows.
International task force identifies key challenges and opportunities in developing clinical trials that target aging biology.
New research reveals why women face more bladder issues with aging and how senolytic therapy might help restore bladder health.
New research shows senolytic therapy can eliminate harmful senescent cells, reactivating immune defenses against prostate cancer.
New research reveals kidneys actively fuel systemic inflammation during aging, offering targets for longevity interventions.
The father of induced pluripotent stem cells discusses regenerative medicine milestones and future therapeutic potential.
Buck Institute unveils Healthspan Horizons AI platform and joins Stanford coalition to develop FDA-grade aging biomarkers.
Josh Duhamel shares candid insights about wishing he'd prioritized yoga, nutrition, and family earlier in his high-intensity career.
Research shows Mediterranean diet preserves kidney function and prevents early diabetic damage through mitochondrial protection.
